Accuray Incorporated to Report First Quarter Fiscal Year 2008 Financial Results

October 12, 2007 at 8:32 AM EDT

SUNNYVALE, Calif., Oct. 12 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will report results for its first quarter fiscal year 2008, ending September 29, 2007, on Wednesday, November 7, 2007 after the market closes.

A conference call to review the results will begin at 2:00 p.m. PST (5:00 p.m. EST) and will be hosted by Euan S. Thomson, Ph.D., president and chief executive officer and Robert E. McNamara, senior vice president and chief financial officer.

The conference call dial-in numbers are (888) 812-8518 (USA) or (913) 312-1446 (International), Access Code: 3456588. In addition, a dial-up replay of the conference call will be available beginning November 7, 2007 at 5:00 p.m. PST (8:00 p.m. EST) and ending on November 21, 2007. The replay telephone number is USA (888) 203-1112, International (719) 457-0820, Access Code: 3456588.

A live webcast of the call will also be available from the Investor Relations section of the corporate Web site at http://www.accuray.com. A webcast replay can be accessed on the corporate Web site beginning Wednesday, November 7, 2007 at approximately 5:00 p.m. PST (8:00 p.m. EST). The replay will remain available until Accuray announces its results for the second quarter of fiscal 2008, ending December 29, 2007.

About the CyberKnife(R) Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system cleared by the FDA to treat tumors anywhere in the body non-invasively and with sub-millimeter accuracy. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver precise, high-dose radiation, minimizing damage to surrounding healthy tissue and eliminating the need for invasive head or body stabilization frames.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 35,000 patients worldwide and currently more than 100 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit http://www.accuray.com.

SOURCE Accuray Incorporated
10/12/2007
CONTACT: Investors, Tom Rathjen, Vice President, Investor Relations,
+1-408-789-4458, trathjen@accuray.com, or Media, Stephanie Tomei, Public
Relations Manager, +1-408-789-4234, stomei@accuray.com, both of Accuray
Incorporated
Web site: http://www.accuray.com